Outpatient Corticosteroid Use in Patients With COVID-19: An Updated Descriptive Analysis

    Basic Details
    Date Posted
    Thursday, June 2, 2022
    Status
    Complete
    Medical Product
    corticosteroids
    Description

    Using the rapidly refreshed version of the Sentinel Distributed Database (SDD) designed for COVID-19 analyses, this report identifies patients with COVID-19 in the outpatient setting and characterizes initiation of oral and injectable corticosteroids. We describe baseline and clinical characteristics among corticosteroid initiators and non-initiators and identify hospitalizations and other complications. This is an updated report of a previous analysis.

    The study period includes data from April 1, 2020 to July 31, 2021. We distributed this request to six Sentinel Data Partners on November 30, 2021.

    Additional Details
    FDA Center
    CDER
    Time Period
    April 1, 2020 - July 31, 2021
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    All individuals
    Data Sources
    Sentinel Distributed Database (SDD)